JPRN-UMIN000006928招募中未知
Efficacy and safety of CH-001 in patients with chronic hepatitis C or NAFLD/NASH (placebo comparative study) - Use of CH-001 in HCV or NAFLD/NASH
Kyoundo Hospital0 个研究点目标入组 40 人开始时间: 2011年12月21日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •[All subjects] 1) Decompensated cirrhosis 2) Other hepatitis virus infections 3) HIV positive 4) Serious chronic bacterial infections 5) Malignant tumour 6) Autoimmune hepatic disorders 7) Alcoholic hepatic disorders or daily alcoholic intake of more than 20g/day 8) Drug-induced hepatic disorders 9) Fulminant hepatitis 10) Biliary disorders 11) Cardiac, renal, or spleen complications requiring hospitalized therapy 12) Sensory disorders due to severe peripheral circulatory disorders 13) During pregnancy/breast feeding, presenting signs of pregnancy, or planning to be pregnant 14) Anti-oxidative therapy within 4 weeks before screening 15) Implantable medical electronics (MEs), life-sustaining MEs, or body-worn MEs [HepC] 1) Interferon and/or ribavirin therapy within 26 weeks before screening 2) Therapy with choleretics, glycyrrhizin compounds, or others within 4 weeks before screening [NAFLD/NASH] 1) Start of therapy with insulin sensitizers, lipid lowering drugs, or others within 4 weeks before screening 2) Start of dietary and/or exercise therapy within 4 weeks before screening 3) Surgical treatments for severe obesity within 4 weeks before screening
研究者
相似试验
尚未招募
1 期
Role of efficacy of Chandasava and Drakshasava in Alcohol Deaddiction.CTRI/2023/09/057906ational Institute of Ayurveda
已完成
不适用
Prospective study of the efficacy and safety of chemotherapy for metastatic or progressive sarcomatoid carcinoma of the lung (carcinoma with pleomorphic, sarcomatoid, or sarcomatous elements) Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 1201/North East Japan Study Group 024Metastatic or progressive sarcomatoid carcinoma of the lung (carcinoma with pleomorphic, sarcomatoid, or sarcomatous elements)JPRN-UMIN000008707Hokkaido Lung Cancer Clinical Study Group North East Japan Study Group30
进行中（未招募）
2 期
A phase II study of S-005151 in patients with chronic liver diseaseChronic liver disease - Liver cirrhosis (alcoholic, non-alcoholic, HBV, or HCV)D008103JPRN-jRCT2031200232Terai Shuji10
已完成
不适用
An evaluation of the effect of chlorhexidine in combination with sodium perborate on gingivitis, plaque and tooth surface stainingCondition 1: gingivitis. Condition 2: tooth surface staining.Chronic gingivitisPosteruptive colour changes of dental hard tissuesIRCT201102245900N1Hamedan dental faculty40
已完成
不适用
The clinical trial for safety and efficacy of chronic hepatitis therapeutics agent, 3-oxygelmillpropionic acid polymer for pancreatic cancer (Phase 1)Resectable pancreatic cancerJPRN-UMIN000027441Osaka University10